Journal List > J Korean Soc Menopause > v.18(3) > 1052080

TOOLS
Kim, Jung, and Lee: The Necessity of Thyroid Function Test of Perimenopausal Women with Menopausal Symptoms
Original Article
The Journal of Korean Society of Menopause

The Journal of Korean Society of Menopause 2012; 18(3): 174-179.

Published online: 31 December 2012

DOI: https://doi.org/10.6118/jksm.2012.18.3.174

The Necessity of Thyroid Function Test of Perimenopausal Women with Menopausal Symptoms

Young Sun Kim, M.D., Eun Young Jung, M.D., Bo Yeon Lee, M.D., Ph.D.

Department of Obstetrics and Gynecology, Kyung Hee University College of Medicine, Seoul, Korea.

Address for Correspondence: Bo Yeon Lee, Department of Obstetrics and Gynecology, Kyung Hee University College of Medicine, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-872, Korea. Tel: +82-2-958-8314, Fax: +82-2-958-8328, bylcm@naver.com

Received 21 October 2012       Revised 22 October 2012       Accepted 7 November 2012

Copyright © 2012 by The Korean Society of Menopause

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).

Abstract

Objectives

Hormone therapy is generally chosen to treat women who are experiencing menopausal symptoms. Knowing the overlapping symptoms between menopause and thyroid diseases as well as their increasing trend, it is crucial to differentially diagnose among the two types of diseases. The study is focused on the thyroid function test (TFT) and its significance. It also reflects those who are in the menopausal transition state, suffering from premenopausal symptoms, and therefore, want to be treated with hormone therapy.

Methods

Endocrinologic diagnosis for menopause was performed in 139 patients who complained of menopausal symptoms and irregular menstruation within the past year and hence, visited the Department of Obstetrics and Gynecology, Kyung Hee University Hospital in order to obtain consultation from January 2007 to March 2011. We made observations using the retrograde method. Among these women, 43 patients tested for TFT for their atypical menopausal symptoms.

Results

Among the 43 patients who tested for TFT, 10 patients showed abnormal TFT and 3 patients who did not take TFT at our department were found to have the thyroid disease later by other clinics.

Conclusion

In order to differentiate thyroid disease, practical guidelines should be prepared for the management of women with menopausal transition.

Keywords: Hormone relpacement therapy, Perimenopause, Thyroid diseases

Figures and Tables

Fig. 1
Results of the thyroid function test in this study. E2: estradiol, FSH: follicle stimulating hormone, LH: luteinizing hormone, TFT: thyroid function test
jksm-18-174-g001
Table 1
Comparison of patient characteristics
jksm-18-174-i001

Value are presented as mean ± standard deviation. E2: estradiol, FSH: follicle stimulating hormone

Table 2
Detailed hormonal profile in atypical menopausal symptom group (n = 43)
jksm-18-174-i002

N: number of patients, FSH: follicle stimulating hormone

References

1. World Health Organization. Research on the menopause in the 1990s. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser. 1996. 866:1–107.
2. Bruce D, Rymer J. Symptoms of the menopause. Best Pract Res Clin Obstet Gynaecol. 2009. 23:25–32.
3. Birkhauser MH, Panay N, Archer DF, Barlow D, Burger H, Gambacciani M, et al. Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric. 2008. 11:108–123.
4. Badawy A, State O, Sherief S. Can thyroid dysfunction explicate severe menopausal symptoms? J Obstet Gynaecol. 2007. 27:503–505.
5. Shifren JL, Schiff I. Berek JS, editor. Menopause. Berek & Novak's gynecology. 2007. 14th ed. Philadelphia: Lippincott Williams & Wilkins;1323–1340.
6. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility. 2005. 7th ed. Philadelphia: Lippincott Williams & Wilkins.
7. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril. 2001. 76:874–878.
8. Rymer J, Morris EP. Extracts from "Clinical evidence": menopausal symptoms. BMJ. 2000. 321:1516–1519.
9. Practice Committee of American Society for Reproductive Medicine. The menopausal transition. Fertil Steril. 2008. 90:S61–S65.
10. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas. 2008. 61:4–16.
11. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992. 7:1342–1346.
12. Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia DE, Soules MR. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab. 1996. 81:2742–2745.
13. Pearce EN. Thyroid dysfunction in perimenopausal and postmenopausal women. Menopause Int. 2007. 13:8–13.
14. Mitrou P, Raptis SA, Dimitriadis G. Thyroid disease in older people. Maturitas. 2011. 70:5–9.
15. Schindler AE. Thyroid function and postmenopause. Gynecol Endocrinol. 2003. 17:79–85.
16. Sowers M, Luborsky J, Perdue C, Araujo KL, Goldman MB, Harlow SD. Thyroid stimulating hormone (TSH) concentrations and menopausal status in women at the mid-life: SWAN. Clin Endocrinol (Oxf). 2003. 58:340–347.
17. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med. 2001. 344:1743–1749.
TOOLS
Similar articles